Efficient Cas9-based Genome Editing Using CRISPR Analysis Webtools in Severe Early-onset-obesity Patient-derived iPSCs.
CRISPR/Cas9
analysis webtools
gene editing
hiPSC
Journal
Current protocols
ISSN: 2691-1299
Titre abrégé: Curr Protoc
Pays: United States
ID NLM: 101773894
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
entrez:
11
8
2022
pubmed:
12
8
2022
medline:
16
8
2022
Statut:
ppublish
Résumé
The CRISPR system is an adaptive defense mechanism used by bacteria and archaea against viruses and plasmids. The discovery of the CRISPR-associated protein Cas9 and its RNA-guided cleavage mechanism marked the beginning of a new era in genomic engineering by enabling the editing of a target region in the genome. Gene-edited cells or mice can be used as models for understanding human diseases. Given its high impact in functional genomic experiments on different model systems, several CRISPR/Cas9 protocols have been generated in the past years. The technique uses a straightforward "cut and stitch" mechanism, but requires an accurate step-by-step design. One of the key points is the use of an efficient programmable guide RNA to increase the rate of success in obtaining gene-specific edited clones. Here, we describe an efficient editing protocol using a ribonucleotide protein (RNP) complex for homology-directed repair (HDR)-based correction of a point mutation in an induced pluripotent stem cell (iPSC) line generated from a 14-year-old patient with severe early-onset obesity carrying a de novo variant of ARNT2. The resulting isogenic iPSC line, named CUIMCi003-A-1, has a normal karyotype, expresses stemness markers, and can be differentiated into progenies from all three germ layers. We provide a detailed workflow for designing a single guide RNA and donor DNA, and for isolating clonal human iPSCs edited with the desired modification. This article also focuses on parameters to consider when selecting reagents for CRISPR/Cas9 gene editing after testing their efficiency with in silico tools. © 2022 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Design of sgRNAs and PCR primers Basic Protocol 2: Testing the efficiency of sgRNAs Basic Protocol 3: Design of template or donor DNA Basic Protocol 4: Targeted gene editing Basic Protocol 5: Selection of positive clones Basic Protocol 6: Freezing, thawing, and expansion of cells Basic Protocol 7: Characterization of edited cell lines.
Identifiants
pubmed: 35950852
doi: 10.1002/cpz1.519
pmc: PMC9377717
mid: NIHMS1822542
doi:
Substances chimiques
RNA, Guide
0
DNA
9007-49-2
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e519Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK026687
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022 The Authors. Current Protocols published by Wiley Periodicals LLC.
Références
Stem Cell Res. 2021 Jul;54:102432
pubmed: 34214899
Nat Biotechnol. 2013 Sep;31(9):827-32
pubmed: 23873081
Genome Res. 2014 Jun;24(6):1012-9
pubmed: 24696461
Nature. 2014 Mar 6;507(7490):62-7
pubmed: 24476820
Nat Biotechnol. 2014 Jul;32(7):670-6
pubmed: 24752079
Nat Methods. 2013 Oct;10(10):957-63
pubmed: 24076990
Cell. 2014 Feb 27;156(5):935-49
pubmed: 24529477
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W401-7
pubmed: 24861617
J Biotechnol. 2015 Aug 20;208:44-53
pubmed: 26003884
Mol Ther Nucleic Acids. 2019 Jun 7;16:73-81
pubmed: 30852378
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Protein Cell. 2022 May;13(5):316-335
pubmed: 33945139
Nucleic Acids Res. 2004 Jul 13;32(12):3683-8
pubmed: 15252152
Nat Biotechnol. 2013 Sep;31(9):839-43
pubmed: 23934178
Nat Rev Genet. 2010 Sep;11(9):636-46
pubmed: 20717154
Nature. 2008 Jan 10;451(7175):141-6
pubmed: 18157115
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Cell Stem Cell. 2007 Jun 7;1(1):55-70
pubmed: 18371336
Methods Enzymol. 2019;616:241-263
pubmed: 30691645
Nature. 2007 Jul 19;448(7151):318-24
pubmed: 17554336
Nat Biotechnol. 2014 Mar;32(3):279-284
pubmed: 24463574
Nucleic Acids Res. 2020 May 21;48(9):5037-5053
pubmed: 32315032
Elife. 2014 Dec 15;3:e04766
pubmed: 25497837
Elife. 2013 Jan 29;2:e00471
pubmed: 23386978